These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21829172)

  • 61. Insulin-producing cells from embryonic stem cells experimental considerations.
    Roche E; Ensenat-Waser R; Vicente-Salar N; Santana A; Zenke M; Reig JA
    Methods Mol Biol; 2007; 407():295-309. PubMed ID: 18453263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro generation of functional insulin-producing cells from lipoaspirated human adipose tissue-derived stem cells.
    Mohamad Buang ML; Seng HK; Chung LH; Saim AB; Idrus RB
    Arch Med Res; 2012 Jan; 43(1):83-8. PubMed ID: 22374243
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Insulin-producing cells derived from stem cells: recent progress and future directions.
    Santana A; Enseñat-Waser R; Arribas MI; Reig JA; Roche E
    J Cell Mol Med; 2006; 10(4):866-83. PubMed ID: 17125591
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Can pancreatic duct-derived progenitors be a source of islet regeneration?
    Xia B; Zhan XR; Yi R; Yang B
    Biochem Biophys Res Commun; 2009 Jun; 383(4):383-5. PubMed ID: 19324022
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?
    Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Production of beta-cells from human embryonic stem cells.
    Baetge EE
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():186-94. PubMed ID: 18834446
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine.
    Halban PA
    Nat Cell Biol; 2004 Nov; 6(11):1021-5. PubMed ID: 15516994
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acquisition of Dynamic Function in Human Stem Cell-Derived β Cells.
    Velazco-Cruz L; Song J; Maxwell KG; Goedegebuure MM; Augsornworawat P; Hogrebe NJ; Millman JR
    Stem Cell Reports; 2019 Feb; 12(2):351-365. PubMed ID: 30661993
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of Islet Organoids from H9 Human Embryonic Stem Cells in Biomimetic 3D Scaffolds.
    Wang W; Jin S; Ye K
    Stem Cells Dev; 2017 Mar; 26(6):394-404. PubMed ID: 27960594
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diabetes mellitus: a potential target for stem cell therapy.
    Burns CJ; Persaud SJ; Jones PM
    Curr Stem Cell Res Ther; 2006 May; 1(2):255-66. PubMed ID: 18220871
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
    Dadheech N; James Shapiro AM
    Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro-generation of surrogate islets from adult stem cells.
    Peck AB; Ramiya V
    Transpl Immunol; 2004 Apr; 12(3-4):259-72. PubMed ID: 15157920
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro models of pancreatic differentiation using embryonic stem or induced pluripotent stem cells.
    Higuchi Y; Shiraki N; Kume S
    Congenit Anom (Kyoto); 2011 Mar; 51(1):21-5. PubMed ID: 21129040
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Understanding pancreas development for β-cell repair and replacement therapies.
    Raducanu A; Lickert H
    Curr Diab Rep; 2012 Oct; 12(5):481-9. PubMed ID: 22782495
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Stem cell therapy for diabetes mellitus: progress, prospects and challenges].
    Urbán SV; Kiss J; Vas V; Kovács J; Uher F
    Orv Hetil; 2006 Apr; 147(17):791-7. PubMed ID: 16780187
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells.
    Toyoda T; Mae S; Tanaka H; Kondo Y; Funato M; Hosokawa Y; Sudo T; Kawaguchi Y; Osafune K
    Stem Cell Res; 2015 Mar; 14(2):185-97. PubMed ID: 25665923
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Resveratrol ameliorates the maturation process of β-cell-like cells obtained from an optimized differentiation protocol of human embryonic stem cells.
    Pezzolla D; López-Beas J; Lachaud CC; Domínguez-Rodríguez A; Smani T; Hmadcha A; Soria B
    PLoS One; 2015; 10(3):e0119904. PubMed ID: 25774684
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells.
    Manzar GS; Kim EM; Zavazava N
    J Biol Chem; 2017 Aug; 292(34):14066-14079. PubMed ID: 28360105
    [TBL] [Abstract][Full Text] [Related]  

  • 80. I. How can you choose the fate of iPSCs and stem cells, Regeneration or Carcinogenesis? A hypothetical insight.: II. Modelling human beta cell development with pluripotent stem cells.
    Seno M; Nostro MC
    J Stem Cells Regen Med; 2020; 16(2):90-91. PubMed ID: 33414585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.